Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01882348 · ClinicalTrials.gov registry record · NA
Changing Pediatric Office Systems Nationally to Address Parental Tobacco Use
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 3,888
- Enrollment target
NCT01882348: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01882348 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 3,888 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (177% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01882348, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,888 participants
- Enrollment target
Study Summary
The proposed study is a Cluster Randomized Controlled Trial designed to test the sustainability of a previously developed, tested, effectively implemented tobacco control strategy-the CEASE intervention, employing state of the art tobacco dependence treatment for parents who smoke.
Primary Outcome
• Delivery of cessation assistance, defined as prescribing medication, or enrolling in the quitline or other program
Interventions
- BEHAVIORAL CEASE Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,888 participants |
| Start Date | 2015-04-14 |
| Est. Completion | 2017-10-26 |
| Phase | NA |
What the finished NCT01882348 record still lists
NCT01882348 is an interventional study that assigns participants to a tested intervention. Its 3,888 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (177% higher).
The record links to 0 conditions, and to 1 intervention - of which CEASE Intervention is the first listed.
NCT01882348 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01882348 about?
NCT01882348 is a clinical study titled "Changing Pediatric Office Systems Nationally to Address Parental Tobacco Use". The proposed study is a Cluster Randomized Controlled Trial designed to test the sustainability of a previously developed, tested, effectively implemented tobacco control strategy-the CEASE intervention, employing state of the art tobacco dependence treatment for parents who smoke.
What is the current status of trial NCT01882348?
This trial is currently completed. It is a NA study. The enrollment target is 3,888 participants. The study started on 2015-04-14. Estimated completion is 2017-10-26.
What interventions are being tested in trial NCT01882348?
The interventions under investigation include: CEASE Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01882348?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01882348's enrollment target sits among peer trials
3,888 36th of 2000 higher than 1,965 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05919342 · 3,904 participants · NA
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT03936335 · 3,930 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
- NCT05879926 · 3,960 participants · Phase 3
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI